Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Antibe Therapeutics Inc(Pre-Merger) ATBPF

Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug,... see more

GREY:ATBPF - Post Discussion

Antibe Therapeutics Inc(Pre-Merger) > Total outstanding shares post holding co absorption
View:
Post by WalkOverTheStrt on Apr 18, 2021 5:44pm

Total outstanding shares post holding co absorption

Realize there is not a confirmed date this will occur (Am looking fwd to it be done and moving onward) but curious what all are predicting in final share count fully diluted post this being completed?

I'm expecting 29M to holding co and total around 75m. Anyone have their guesses they'd like to put out for fun?

Holding co 29,000,000
Shares Outstanding 38,700,000
Options and RSUs 3,500,000
Warrants 4,200,000
Total 75,400,000
Comment by StockingUp21 on Apr 18, 2021 5:53pm
does this mean you think 40% dilution for this IP?! 
Comment by WalkOverTheStrt on Apr 18, 2021 7:15pm
StockingUp21 I didn't say I was right :) and I hope I am way over.. I'm taking a very dilutive view for my model. 
Comment by Marky1 on Apr 18, 2021 6:40pm
I put the total at not more than 60 million shares...but the bottom line is what figure does Bayer put as the value of ATE.. What will they pay to acquire Otenaproxesul and relabel it as New  and Improved Alleve...stronger, longer lasting and 1/4 the dosage needed for superior results and no stomach problems...My call is way over 2B$ USD Bayer is a business with very ruthless guidelines ...more  
Comment by CalgaryATE on Apr 18, 2021 7:33pm
Current total outstanding shares for ATE is 56 million. My guess would be that Holdings shareholders would receive 10 million shares (10/66 = 15%) for their 15% of royalties. Wallace would get about 3 million (owns 32% of Holdings) and Legault 2 million (20% of Holdings), while original founders would split up the remaining 5 million shares. Total outstanding shares after amalgamation of 66 ...more  
Comment by Marky1 on Apr 18, 2021 8:17pm
Current shares is 46 million
Comment by CalgaryATE on Apr 18, 2021 9:01pm
Common shares are about 46 million, but if you add in RSUs, warrants and options it's currently about 56 million fully diluted.
Comment by MrMugsy on Apr 18, 2021 8:18pm
Funny enough Calgary ... been using 66M as fully diluted a while now.  Like your number !!!
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities